Cargando…
Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis
Many trials have explored the efficacy of individual drugs and drug combinations to treat bancroftian filariasis. This narrative review summarizes the current evidence for drug management of bancroftian filariasis. Diethylcarbamazine (DEC) remains the prime antifilarial agent with a well-established...
Autores principales: | Fernando, Sumadhya Deepika, Rodrigo, Chaturaka, Rajapakse, Senaka |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018634/ https://www.ncbi.nlm.nih.gov/pubmed/21234244 http://dx.doi.org/10.1155/2011/175941 |
Ejemplares similares
-
Compliance with Primary Malaria Chemoprophylaxis: Is Weekly Prophylaxis Better Than Daily Prophylaxis?
por: Rodrigo, Chaturaka, et al.
Publicado: (2020) -
Current immunological and molecular tools for leptospirosis: diagnostics, vaccine design, and biomarkers for predicting severity
por: Rajapakse, Senaka, et al.
Publicado: (2015) -
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015) -
Pharmacological management of tetanus: an evidence-based review
por: Rodrigo, Chaturaka, et al.
Publicado: (2014) -
The 'hidden' burden of malaria: cognitive impairment following infection
por: Fernando, Sumadhya D, et al.
Publicado: (2010)